| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |